このページの翻訳は実験的なもので、現在開発中です。お待ちしております
Viking Therapeutics マネジメント
マネジメント 基準チェック /24
現在、CEO に関する十分な情報がありません。
主要情報
Brian Lian
最高経営責任者
US$12.6m
報酬総額
| CEO給与比率 | 4.9% |
| CEO在任期間 | 12yrs |
| CEOの所有権 | 1.7% |
| 経営陣の平均在職期間 | 5.1yrs |
| 取締役会の平均在任期間 | 10.3yrs |
経営陣の近況
Recent updates
Viking Therapeutics: Market Rightly Excited By GLP-1 Promise -- A Buy Ahead Of Data
Sep 25Companies Like Viking Therapeutics (NASDAQ:VKTX) Can Afford To Invest In Growth
Sep 07
Viking Therapeutics: GLP-1/GIP Receptor Agonist And Its Competitive Landscape
Aug 30Viking Therapeutics: Better-Than-Expected Trial Timelines While Pipeline Expands
Jul 25We Think Viking Therapeutics (NASDAQ:VKTX) Can Easily Afford To Drive Business Growth
Apr 26Viking Therapeutics: Future Weight Loss Heavyweight?
Apr 02We're Hopeful That Viking Therapeutics (NASDAQ:VKTX) Will Use Its Cash Wisely
Jan 09We're Not Very Worried About Viking Therapeutics' (NASDAQ:VKTX) Cash Burn Rate
Sep 21Viking Therapeutics (NASDAQ:VKTX) Is In A Good Position To Deliver On Growth Plans
Jun 07We're Not Very Worried About Viking Therapeutics' (NASDAQ:VKTX) Cash Burn Rate
Mar 05Viking Therapeutics: Playing Second Fiddle To Madrigal
Aug 30We Think Viking Therapeutics (NASDAQ:VKTX) Can Afford To Drive Business Growth
Jul 13Revisiting Viking Therapeutics
Apr 20We Think Viking Therapeutics (NASDAQ:VKTX) Can Afford To Drive Business Growth
Apr 12We Think Viking Therapeutics (NASDAQ:VKTX) Can Afford To Drive Business Growth
Dec 17Viking Therapeutics: Remaining Bullish And Sticking To My Plan
Aug 27Viking Therapeutics soars 11% on encouraging VK0214 data in rare metabolic disorder
Jun 17Have Insiders Been Selling Viking Therapeutics, Inc. (NASDAQ:VKTX) Shares This Year?
Jan 13Viking Therapeutics announces senior management appointments
Jan 06Do Institutions Own Viking Therapeutics, Inc. (NASDAQ:VKTX) Shares?
Dec 09
Viking Therapeutics: Progressing Steadily, But Concerns Remain
Nov 29CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$97m |
| Mar 31 2024 | n/a | n/a | -US$94m |
| Dec 31 2023 | US$13m | US$615k | -US$86m |
| Sep 30 2023 | n/a | n/a | -US$81m |
| Jun 30 2023 | n/a | n/a | -US$74m |
| Mar 31 2023 | n/a | n/a | -US$72m |
| Dec 31 2022 | US$5m | US$612k | -US$69m |
| Sep 30 2022 | n/a | n/a | -US$62m |
| Jun 30 2022 | n/a | n/a | -US$59m |
| Mar 31 2022 | n/a | n/a | -US$57m |
| Dec 31 2021 | US$4m | US$594k | -US$55m |
| Sep 30 2021 | n/a | n/a | -US$54m |
| Jun 30 2021 | n/a | n/a | -US$50m |
| Mar 31 2021 | n/a | n/a | -US$44m |
| Dec 31 2020 | US$5m | US$577k | -US$39m |
| Sep 30 2020 | n/a | n/a | -US$36m |
| Jun 30 2020 | n/a | n/a | -US$32m |
| Mar 31 2020 | n/a | n/a | -US$31m |
| Dec 31 2019 | US$4m | US$525k | -US$26m |
| Sep 30 2019 | n/a | n/a | -US$24m |
| Jun 30 2019 | n/a | n/a | -US$24m |
| Mar 31 2019 | n/a | n/a | -US$23m |
| Dec 31 2018 | US$1m | US$485k | -US$22m |
| Sep 30 2018 | n/a | n/a | -US$21m |
| Jun 30 2018 | n/a | n/a | -US$20m |
| Mar 31 2018 | n/a | n/a | -US$19m |
| Dec 31 2017 | US$805k | US$440k | -US$21m |
報酬と市場: Brianの 総報酬 ($USD 12.63M ) は、 US市場 ($USD 8.44M ) の同規模の企業の平均を上回っています。
報酬と収益: Brianの報酬は増加しましたが、会社は利益を上げていません。
CEO（最高経営責任者
Brian Lian (58 yo)
12yrs
在職期間
US$12,628,061
報酬
Dr. Brian Lian, Ph D., served as Director at Apricus Biosciences, Inc. He has been the Chief Executive Officer and President at Viking Therapeutics, Inc. since September 24, 2012. Dr. Lian has been an Inde...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| President | 12yrs | US$12.63m | 1.72% $ 117.7m | |
| Chief Financial Officer | 5.1yrs | US$3.50m | 0.035% $ 2.4m | |
| Chief Operating Officer | 3.7yrs | US$3.51m | 0.19% $ 12.7m | |
| Vice President of Finance & Administration | 6.4yrs | US$619.56k | データなし | |
| Senior Vice President of Pharmaceutical Development | 1.7yrs | データなし | データなし |
5.1yrs
平均在職期間
58.5yo
平均年齢
経験豊富な経営陣: VKTXの経営陣は経験豊富で経験豊富です（平均在職期間は5年）。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| President | 12yrs | US$12.63m | 1.72% $ 117.7m | |
| Scientific Advisor | no data | データなし | データなし | |
| Independent Director | 10.3yrs | US$169.37k | 0.10% $ 6.9m | |
| Independent Director | 10.3yrs | US$192.77k | 0.0086% $ 585.2k | |
| Independent Director | 7.2yrs | US$189.62k | 0.027% $ 1.8m | |
| Scientific Advisor | no data | データなし | データなし | |
| Scientific Advisor | no data | データなし | データなし | |
| Scientific Advisor | no data | データなし | データなし | |
| Scientific Advisor | no data | データなし | データなし | |
| Independent Chairman | 10.3yrs | US$222.72k | 0.043% $ 3.0m | |
| Scientific Advisor | no data | データなし | データなし | |
| Independent Director | 5.2yrs | US$178.65k | 0% $ 0 |
10.3yrs
平均在職期間
63.5yo
平均年齢
経験豊富なボード: VKTXの 取締役会 は経験豊富で 経験豊富 です ( 10.1年の平均在任期間)。